Inhibition of rotavirus infection in vitro and in vivo by a synthetic peptide from VP4

Vaccine

Volumn 16, Issue 9-10, 1998, Pages 916-920

  Ijaz, M K ^a   Nur E Kamal, M S A ^b   Dar, F K ^b,c   Uduman, S ^b   Redmond, M J ^d   Attah Poku, S K ^d   Dent, D ^d   Babiuk, L A ^d,e  

^a HH Shaikh Khalifa Res Ctr for R   (United Arab Emirates)

^b UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^c Ministry of Health United Arab Emirates   (United Arab Emirates)

^d UNIVERSITY OF SASKATCHEWAN   (Canada)

^e UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Anti viral agents; Rotavirus vaccine; VP4 peptide

Indexed keywords

EPITOPE; PEPTIDE VP4; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; INFECTION CONTROL; MOUSE; NEWBORN; NONHUMAN; ORAL DRUG ADMINISTRATION; PLAQUE FORMING CELL; PRIORITY JOURNAL; ROTAVIRUS; VIRUS ADSORPTION; VIRUS CELL INTERACTION; VIRUS INFECTION;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; CAPSID; CAPSID PROTEINS; CATTLE; CELL LINE; MICE; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; RECEPTORS, VIRUS; ROTAVIRUS; ROTAVIRUS INFECTIONS; TRYPSIN; VACCINES, SYNTHETIC; VIRAL VACCINES;

EID: 0032077062     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00298-3     Document Type: Article

References (28)

1. 1 Ijaz, M.K., Attah-Poku, S.A., Redmond, M.J., Parker, M.D., Sabara, M.I, and Babiuk, L.A. Heterotypic passive protection induced by synthetic peptides corresponding to VP7 and VP4 of bovine rotavirus. J. Virol. 1991, 65, 3106-3113.
2. 2 Estes, M.K. Advances in molecular biology: impact on rotavirus vaccine development. J. Infect. Dis. 1996, 174, S37-S46.
3. 3 Franco, M.A., Feng, N. and Greenberg, H.B. Molecular determinants of immunity and pathogenicity of rotavirus infection in the mouse model. J. Infect. Dis. 1996, 174, S47-S50.
4. 4 Herrmann, J.E., Chen, S.C. and Fynan, E.F. et al. Protection against rotavirus infections by DNA vaccination. J. Infect. Dis. 1996, 174, S93-S97.
5. 5 Ward, R.L. Mechanism of protection against rotavirus in human and mice. J. Infect. Dis. 1996, 174, S51-S58.
6. 6 Offit, P.A. Host factors associated with protection against rotavirus disease: the skies are clearing. J. Infect. Dis. 1996, 174, S59-S64.
7. 7 Kapikian, A.Z., Hoshino, Y., Chanock, R.M. and Perex-Schael, I. Efficacy of quadrivalent rhesus rotavirus-based human rotavirus vaccine aimed at preventing severe rotavirus diarrhea in infants and young children. J. Infect. Dis. 1996, 174, S65-S72.
8. 8 Clark, H.F., Offit, P.A. and Ellis, R.W. et al. The development of multivalent bovine rotavirus (Strain WC3) reassortant vaccine for infants. J. Infect. Dis. 1996, 174, S73-S80.
9. 9 Mackow, E.R., Vo, P.T., Broome, R., Bass, D.M. and Greenberg, H.B. Immunization with baculovirus expressed VP4 protein passively protects against simian and murine rotavirus challenge. J. Virol. 1990, 64, 1698-1703.
10. 10 Redmond, M.J., Bielefeldt Ohmann, H. and Hughes, H.P.A. et al. Rotavirus particles function as immunological carriers for the delivery of peptides from infectious agents and endogenous proteins. Mol. Immunol. 1991, 28, 269-278.
11. 11 Redmond, M.J., Ijaz, M.K. and Parker, M.D. et al. Assembly of recombinant rotavirus proteins into virus-like particles and assessment of vaccine potential. Vaccine 1993, 11, 273-281.
12. 12 Mackow, E.R., Barnett, J., Chow, H. and Greenberg, H.B. The rhesus rotavirus outer capsid protein VP4 functions as a hemagglutinin and is antigenically conserved when expressed by a baculovirus recombinant. J. Virol. 1989, 63, 1661-1668.
13. 13 Fiore, L., Greenberg, H.B. and Mackow, E.R. The VP8 fragment of VP4 is the rhesus rotavirus hemagglutinin. Virol. 1991, 181, 553-563.
14. 14 Ruggeri, F.M. and Greenberg, H.B. Antibodies to the trypsin cleavage peptide VP8* neutralize rotavirus by inhibiting binding of virions to target cells in culture. J. Virol. 1991, 65, 2211-2219.
15. 15 Lee, J., Babiuk, L.A., Harland, R., Gibbons, E., Elazhary, Y. and Yoo, D. Immunological response to recombinant VP8* subunit protein of bovine rotavirus in pregnant cattle. J. Gen. Virol. 1995, 76, 2477-2483.
16. 16 Prasad, B.V.V., Burns, J.W., Marietta, E., Estes, M.K. and Chiu, W. Localization of VP4 neutralization sites in rotavirus by three dimensional cryo-electron microscopy. Nature (London) 1990, 343, 476-479
17. 17 Fukuhara, N., Yoshie, O., Kitaoka, S. and Konno, T. Rote of VP3 in human rotavirus infection after its target cell attachment via VP7. J. Virol. 1988, 62, 2209-2218.
18. 18 Aha, P.M. and Sabara, M.I. Development of a rotavirus plaque assay using Sephadex G-75. J. Virol. Methods 1990, 28, 25-32.
19. 19 Ijaz, M.K., Dent, D., Haines, D. and Babiuk, L.A. Development of a murine model to study the pathogenesis of rotavirus infection. Exp. Mol. Path. 1989, 51, 186-204.
20. 20 Ijaz, M.K., Sabara, M.I., Frenchick, P.J. and Babiuk, L.A. Assessment of intestinal damage in rotavirus infected neonatal mice by a D-xylose absorption test. J. Virol. Methods 1987, 18, 153-157.
21. 21 Babiuk, L.A., Mohamed, K., Spence, L., Fauvel, M. and Petro, R. Rotavirus isolation and cultivation in the presence of trypsin. J. Clin. Microbiol. 1977, 6, 610-617.
22. 22 Sabara, M., Gilchrist, J.E., Hudson, G.R. and Babiuk, L.A. Preliminary characterization of an epitope involved in neutralization and cell attachment that is localized on the major bovine rotavirus glycoprotein. J. Virol. 1985, 53, 58-66.
23. 23 Liang, X., Babiuk, L.A., van Drunen Littel-van den Hurk, S., Fitzpatrick, D.R. and Zamb, T.J. Bovine herpes virus 1 attachment to permissive cells is mediated by its major glycoproteins gI, gIII, and gIV. J. Virol. 1991, 65, 1124-1132.
24. 24 Willoughby, R.E., Yolken, R.H. and Schnarr, R.L. Rotaviruses specifically bind to the neutral glycosphingolipid asialo-GM1. J. Virol. 1990, 64, 4830-4835.
25. 25 Krivan, H.C., Roberts, D.D. and Ginsburg, V. Many pulmonary pathogenic bacteria bind specifically to the carbohydrate sequence GaINAcB1-4Gal found in some glycolipids. Proc. Natl Acad. Sci. USA 1988, 85, 6157-6161.
26. 26 Potter, A.A., Cox, G., Parker, M. and Babiuk, L.A. The complete nucleotide sequence of bovine rotavirus C486 gene 4 cDNA. Nucleic Acids Res. 1987, 15, 4361.
27. 27 Whitbeck, J.C., Bellow, L. and Lawrence, W.C. Comparison of the bovine herpes virus 1 gl gene and the herpes simplex virus type 1 gB gene. J. Virol. 1988, 62, 3319-3327.
28. 28 Saif, L.J. and Fernandez, F.M. Group A rotavirus veterinary vaccines. J. Infect. Dis. 1996, 174, S98-S106.